234 related articles for article (PubMed ID: 16885528)
1. The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding.
Lin SJ; Lerch TF; Cook RW; Jardetzky TS; Woodruff TK
Reproduction; 2006 Aug; 132(2):179-90. PubMed ID: 16885528
[TBL] [Abstract][Full Text] [Related]
2. TGF-β family co-receptor function and signaling.
Nickel J; Ten Dijke P; Mueller TD
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):12-36. PubMed ID: 29293886
[TBL] [Abstract][Full Text] [Related]
3. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
Keah HH; Hearn MT
J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily.
Hinck AP
FEBS Lett; 2012 Jul; 586(14):1860-70. PubMed ID: 22651914
[TBL] [Abstract][Full Text] [Related]
5. Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face.
Dudas M; Kaartinen V
Curr Top Dev Biol; 2005; 66():65-133. PubMed ID: 15797452
[No Abstract] [Full Text] [Related]
6. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
8. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.
Thompson TB; Woodruff TK; Jardetzky TS
EMBO J; 2003 Apr; 22(7):1555-66. PubMed ID: 12660162
[TBL] [Abstract][Full Text] [Related]
9. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
10. Endocrine Regulation of Energy Balance by Drosophila TGF-β/Activins.
Song W; Ghosh AC; Cheng D; Perrimon N
Bioessays; 2018 Nov; 40(11):e1800044. PubMed ID: 30264417
[TBL] [Abstract][Full Text] [Related]
11. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
12. Homomeric and heteromeric complexes among TGF-β and BMP receptors and their roles in signaling.
Ehrlich M; Horbelt D; Marom B; Knaus P; Henis YI
Cell Signal; 2011 Sep; 23(9):1424-32. PubMed ID: 21515362
[TBL] [Abstract][Full Text] [Related]
13. More than being protective: functional roles for TGF-β/activin signaling pathways at central synapses.
Krieglstein K; Zheng F; Unsicker K; Alzheimer C
Trends Neurosci; 2011 Aug; 34(8):421-9. PubMed ID: 21742388
[TBL] [Abstract][Full Text] [Related]
14. TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.
Pickup MW; Owens P; Moses HL
Cold Spring Harb Perspect Biol; 2017 May; 9(5):. PubMed ID: 28062564
[TBL] [Abstract][Full Text] [Related]
15. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
[TBL] [Abstract][Full Text] [Related]
16. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
19. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP
Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111
[TBL] [Abstract][Full Text] [Related]
20. Modulation of activin and BMP signaling.
Harrison CA; Wiater E; Gray PC; Greenwald J; Choe S; Vale W
Mol Cell Endocrinol; 2004 Oct; 225(1-2):19-24. PubMed ID: 15451563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
